Iota-Carrageenan Nasal Spray in Common ColdBone and Cancer FoundationBone & Cancer Foundation
Respir Res 16:121R. Eccles, B. Winther, S.L. Johnston, P. Robinson at al. Efficacy and safety of iota- carrageenan nasal spray versus placebo in early treatment of the common cold in adults: the ICICC trial. Respir Res., 2015; 16: 121....
Iota-carrageenan is one of a family of naturally occurring gel-forming sulfated polysaccharides and is well-known as a food additive. It is currently undergoing a Phase 2 clinical trials as a nasal spray for the potential prevention and treatment of viral pneumonia caused by SARS-CoV-2 or othe...
International Journal of General Medicine Dovepress open access to scientific and medical research Open Access Full Text Article O r igi n a l R e s e a r c h Development of a nasal spray containing xylometazoline hydrochloride and iota- carrageenan for the symptomatic relief of nasal ...
Iota-carrageenan is a large polysaccharide molecule which is neither absorbed from the respiratory tract nor metabolised. It, therefore, does not have any pharmacological properties. Iota-carrageenan nasal spray has been shown to reduce the titres of respiratory viruses and to reduce the severity of...
Lessons learned from a double-blind randomised placebo-controlled study with a iota-carrageenan nasal spray as medical device in children with acute symptoms of common cold. BMC Complement Altern Med. 2012; doi: 10.1186/1472-6882-12-147Fazekas T, Eickhoff P, Pruckner N, Vollnhofer G, Fisch...
1524Design and Implementation Of ICE-COVID, A Double-Blind Randomised Placebo-Controlled Trial on The Efficacy of Iota-Carrageenan Nasal and Throat Spray for Covid-19 Prophylaxisdoi:10.1093/bjs/znab259.508INTRODUCTION. The severity of Covid-19 infection is associated with viral load. For infection...